These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 6456008

  • 21. [Biliary, renal and fecal elimination and distribution of gold after a single oral administration of auranofin, quantified by the instrumental neutron activation analysis method].
    Benn HP, Schnier C, Bauer E, Seiler KU, Elhöft H, Löffler H.
    Z Rheumatol; 1991; 50(1):32-8. PubMed ID: 2058320
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Characterization of the pathways of cefotiam elimination by clearance approaches in patients following cholecystectomy].
    Terziivanov D, Gerova Z, Vlakhov V.
    Vutr Boles; 1985; 24(6):84-9. PubMed ID: 3868221
    [Abstract] [Full Text] [Related]

  • 24. [Clinical pharmacokinetics of azlocillin].
    Singlas E, Haegel C.
    Presse Med; 1984 Mar 29; 13(13):788-96. PubMed ID: 6231596
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Pharmacokinetics of intramuscular mezlocillin in patients with normal and impaired renal function (author's transl)].
    Brogard JM, Comte F, Kopferschmitt J, Dorner M, Lavillaureix.
    Nouv Presse Med; 1982 Feb 04; 11(5 Pt 2):340-6. PubMed ID: 6460973
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Kinetics and disposition of hexarelin, a peptidic growth hormone secretagogue, in rats.
    Roumi M, Marleau S, du Souich P, Maggi T, Deghenghi R, Ong H.
    Drug Metab Dispos; 2000 Jan 04; 28(1):44-50. PubMed ID: 10611139
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Pharmacokinetic studies with silymarin in human serum and bile.
    Lorenz D, Lücker PW, Mennicke WH, Wetzelsberger N.
    Methods Find Exp Clin Pharmacol; 1984 Oct 04; 6(10):655-61. PubMed ID: 6513680
    [Abstract] [Full Text] [Related]

  • 33. [Excretion in bile and clinical study of T-1220 (piperacillin) in biliary tract diseases (author's transl)].
    Saito T, Yamada Y.
    Jpn J Antibiot; 1977 Oct 04; 30(10):835-9. PubMed ID: 592486
    [Abstract] [Full Text] [Related]

  • 34. Renal, biliary and intestinal clearance of sotalol enantiomers in rat model: evidence of intestinal exsorption.
    Carr RA, Pasutto FM, Foster RT.
    Biopharm Drug Dispos; 1996 Nov 04; 17(8):725-35. PubMed ID: 8950050
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
    Smith WB, Dowell JA, Pratt RD.
    Clin Ther; 2007 Jul 04; 29(7):1368-80. PubMed ID: 17825688
    [Abstract] [Full Text] [Related]

  • 38. [Kinetics of cefixime biliary clearance in cholecystectomized patients].
    Westphal JF, Jehl F, Brogard JM.
    Therapie; 1994 Jul 04; 49(1):35-9. PubMed ID: 8091363
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.